Injecting Drug Use Community Intervention Trial
A Randomized Community Intervention Trial on Reducing HIV Infection Among Drug Users Attending Methadone Maintenance Treatment(MMT) and Preventing Secondary Transmission From HIV Positive Clients to Their Sexual Partners in China
Sponsor: Guangxi Center for Disease Control and Prevention
This PHASE3 trial investigates HIV and HIV Infections and is currently ongoing. Guangxi Center for Disease Control and Prevention leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Jun 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Guangxi Center for Disease Control and Prevention
- Guizhou Center for Disease Control and Prevention
- National Center for AIDS/STD Control and Prevention, China CDC
- Sichuan Center for Disease Control and Prevention
- Xinjiang Center for Disease Control and Prevention
- Yunnan Center for Disease Control and Prevention
For direct contact, visit the study record on ClinicalTrials.gov .